Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADCIRCA for Pulmonary arterial hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where ADCIRCA was used for Pulmonary arterial hypertension.

Most Reported Side Effects for ADCIRCA

Side Effect Reports % Deaths Hosp.
Dyspnoea 17 18.1% 2 14
Headache 13 13.8% 0 7
Death 10 10.6% 10 2
Anaemia 7 7.5% 0 7
Malaise 7 7.5% 0 4
Oedema peripheral 7 7.5% 2 5
Pneumonia 7 7.5% 0 6
Abdominal distension 6 6.4% 2 3
Fluid retention 5 5.3% 1 3
Nasal congestion 5 5.3% 0 0
Nausea 5 5.3% 0 3

Other Indications for ADCIRCA

Product used for unknown indication (39) Pulmonary hypertension (18)

Other Drugs Used for Pulmonary arterial hypertension

TREPROSTINIL (72,609) MACITENTAN (29,246) AMBRISENTAN (27,852) BOSENTAN (12,387) SELEXIPAG (11,861) RIOCIGUAT (9,158) EPOPROSTENOL (8,508) TADALAFIL (7,679) SILDENAFIL (5,239) ILOPROST (2,828)

Related Pages

ADCIRCA Full Profile All Pulmonary arterial hypertension Drugs ADCIRCA Demographics ADCIRCA Timeline